news

November 12, 2015

Integral Molecular Identifies Key Molecular Interactions Responsible for the Effectiveness of the ZMapp™ Anti-Ebola Virus Cocktail

To support the creation of Ebola virus vaccines and treatments, Integral Molecular, a leader in membrane protein antibody discovery, has identified the key molecular interactions that […]
October 15, 2015

Integral Molecular Awarded $5.5M by the National Institutes of Health to Study Ebola Antibodies to Aid in Vaccine Discovery

With a new $5.5M award from the National Institute of Allergy and Infectious Diseases (NIAID) part of the National Institutes of Health (NIH), Integral Molecular, Inc. […]
July 3, 2015

Cat Got Your Tongue? Not According to New Research

The ability to detect bitter chemicals is thought to have evolved because it helps animals avoid toxic compounds often found in plants. All cats, from pets […]
December 10, 2014

Integral Molecular Identifies Potent Inhibitory Antibodies Against Chikungunya Virus

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, in conjunction with Blood Systems Research Institute (BSRI), has identified potent inhibitory human antibodies against the […]
November 13, 2014

Integral Molecular Awarded $3.5M Contract from NIH to Study Ebola and Hepatitis C Virus Antibody Response

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc. has been awarded a five year $3.5 million contract to study the human immune response to Ebola virus and hepatitis C virus […]
July 17, 2014

Integral Molecular Announces Patent Allowance for Dengue Research Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein research, announces the issuance of a new composition patent protecting dengue reporter virus particles (RVPs). The invention relates […]
March 28, 2014

Integral Molecular Announces Patent Protecting the Use of Lipoparticles for Antibody Discovery

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent protecting the use of Lipoparticles for eliciting antibodies against […]
December 11, 2013

Integral Molecular Identifies Potent Antibody Antagonists Against Ion Channel Pain Target P2X3

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, announces that it has successfully generated potent antibody antagonists targeting the P2X3 ion channel using the […]
November 6, 2013

Integral Molecular Announces Issuance of Third Patent Family, Extending Patent Landscape for Key Lipoparticle Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent and patent family protecting the composition of matter for […]